View Single Post
Old 05-13-2011, 07:10 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,154
Initiation Of Clinical Trial To Evaluate IL-7 (CYT107) And XELODA (R) (Capecitabine)

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard (Lyon), the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS (Grenoble), a diagnostic company specialized in innovative immunomonitoring tests and services, toda...

More...
News is offline   Reply With Quote